Table 4 Characteristics at baseline and after 12 months in the vitamin D and placebo group
From: Plasma profile of microRNA after supplementation with high doses of vitamin D3 for 12 months
Vitamin D group*______________________________ | Placebo group______________________________ | |||
|---|---|---|---|---|
Baseline | 12 months | Baseline | 12 months | |
N | 40 | 40 | 37 | 37 |
Age (years) | 48.9 ± 10.0 | 51.0 ± 10.1 | ||
Smokers (%) | 20.0 | 18.9 | ||
BMI (kg/m2) | 34.4 ± 4.2 | 34.5 ± 4.5 | 34.3 ± 3.1 | 34.5 ± 3.5 |
Systolic blood pressure (mmHg) | 130.7 ± 13.6 | 136.2 ± 16.9 | 130.9 ± 16.1 | 131.6 ± 16.6 |
Diastolic blood pressure (mmHg) | 81.5 ± 10.8 | 84.1 ± 10.5 | 79.4 ± 10.5 | 80.3 ± 8.9 |
HbA1c (%) | 5.62 ± 0.40 | 5.74 ± 0.40 | 5.74 ± 0.42 | 5.80 ± 0.46 |
Serum PTH (pmol/L) | 5.63 ± 1.60 | 4.64 ± 1.55a | 5.79 ± 1.81 | 5.66 ± 2.06 |
Serum 25(OH)D (nmol/L) | 50.2 ± 14.2 | 101.7 ± 17.8a | 53.0 ± 19.1 | 49.6 ± 16.0 |